Men are from mars, but women are not from venus: The benefits of SGLT2 inhibitors after myocardial infarction are independent of gender

Hellenic J Cardiol. 2024 Jan-Feb:75:93-95. doi: 10.1016/j.hjc.2023.09.015. Epub 2023 Sep 23.

Authors

Juan Badimon¹, Carlos G Santos-Gallego²

Affiliations

¹ Atherothrombosis Research Unit, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York City, UK. Electronic address: juan.badimon@mssm.edu.
² Atherothrombosis Research Unit, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York City, UK.

PMID: 37748647
DOI: 10.1016/j.hjc.2023.09.015

No abstract available

Publication types

Editorial

MeSH terms

Female
Humans
Male
Myocardial Infarction* / drug therapy
Myocardial Infarction* / epidemiology
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Sodium-Glucose Transporter 2 Inhibitors